HeartSciences Inc. received a notice from Nasdaq on August 4, 2026, stating it is not in compliance with Listing Rule 5550(b)(1) due to failing to maintain the required $2,500,000 minimum stockholders' equity. The company reported stockholders’ equity of only $226,060 as of April 30, 2026. Nasdaq has granted a 45-day period until September 18, 2026, to submit a compliance plan, with potential for an extension until January 31, 2027. The company intends to rely on the consummation of its proposed all-stock merger with Fortitude Mining Holdings, Inc., announced June 23, 2026, as the basis for regaining compliance. Failure to regain compliance could result in delisting, negatively impacting liquidity and financing capabilities. HeartSciences Inc. operates in the medical technology industry, developing minimally invasive treatments for heart failure.

HeartSciences Inc. entered into Amendment No. 1 to the Agreement and Plan of Merger with Fortitude Mining Holdings, Inc. and its subsidiaries to modify the terms of the previously announced merger agreement dated June 23, 2026. The amendment clarifies redemption mechanics in the A&R LLC Agreement and updates the Parent New Charter to adjust requirements for shareholder action by written consent. HeartSciences is a medical technology company focused on cardiac health diagnostics.

HeartSciences Inc. entered into a Merger Agreement on June 23, 2026, with Fortitude Mining Holdings, Inc. and its subsidiaries to facilitate a merger where Fortitude will survive and HeartSciences will become the sole managing member. The agreement includes management changes, including the appointment of Andrea Childs as CEO and Erik Ellingson as CFO, and retention bonuses for current CEO Andrew Simpson and CFO Danielle Watson. HeartSciences operates in the medical technology industry, focusing on developing and commercializing cardiac health monitoring solutions.

HeartSciences Inc. entered into an Agreement and Plan of Merger with Fortitude Mining Holdings, Inc. and its subsidiary, Fortitude Mining HoldCo, LLC, through a merger sub, Cordis Acquisition, LLC. The company intends to file a Proxy Statement with the SEC to seek stockholder approval for the transactions. HeartSciences Inc. operates in the healthcare technology and medical device industry focusing on cardiac health solutions.

HeartSciences Inc. entered into a merger agreement on June 23, 2026, to acquire Fortitude Mining Holdings, Inc., a Zcash mining platform. The transaction involves a complex restructuring including the creation of a new Class V common stock and the conversion of existing Series C and D preferred stock into Class A common stock. Following the merger, Fortitude equityholders are expected to own approximately 95.0% of the company. HeartSciences is a medical technology company focused on cardiac health diagnostics.